Juliana Elstad

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Vibrato Medical, Inc. is a private company based in an undisclosed location. The American company has developed the first wearable therapeutic ultrasound device for the noninvasive treatment of peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI). The device is designed to promote vasodilation, collateral vessel growth, angiogenesis, and restore perfusion. Vibrato Medical's leadership team has extensive experience in developing and commercializing medical devices and is supported by an experienced board of directors and recognized clinical leaders in the field of PAD. The company's mission is to be the preferred therapeutic system for patients with reduced tissue perfusion. The company was founded by Bobak Azamian and Babak Nazer, and the CEO is Juliana Elstad.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA.

Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA.

Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022.

Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Vibrato Medical, Inc. is a private company based in an undisclosed location. The American company has developed the first wearable therapeutic ultrasound device for the noninvasive treatment of peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI). The device is designed to promote vasodilation, collateral vessel growth, angiogenesis, and restore perfusion. Vibrato Medical's leadership team has extensive experience in developing and commercializing medical devices and is supported by an experienced board of directors and recognized clinical leaders in the field of PAD. The company's mission is to be the preferred therapeutic system for patients with reduced tissue perfusion. The company was founded by Bobak Azamian and Babak Nazer, and the CEO is Juliana Elstad.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of BioVentrix, Inc., MateraCor, Inc. is a southern-based biotech start-up that develops novel approaches to prevent progression and reverse heart failure. The company is based in Aliso Viejo, CA. The company's lead product, Trans-Catheter Myocardial Restoration (TCMR), is an investigational device that consists of an implantable hydrogel and a minimally invasive endocardial delivery system to treat ischemic or non-ischemic heart failure with reduced ejection faction (HFREF). The CEO of the company is Frank A. Ahmann. MateraCor was acquired by BioVentrix, Inc. on January 27, 2022.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Vibrato Medical, Inc. is a private company based in an undisclosed location. The American company has developed the first wearable therapeutic ultrasound device for the noninvasive treatment of peripheral arterial disease (PAD) and chronic limb-threatening ischemia (CLTI). The device is designed to promote vasodilation, collateral vessel growth, angiogenesis, and restore perfusion. Vibrato Medical's leadership team has extensive experience in developing and commercializing medical devices and is supported by an experienced board of directors and recognized clinical leaders in the field of PAD. The company's mission is to be the preferred therapeutic system for patients with reduced tissue perfusion. The company was founded by Bobak Azamian and Babak Nazer, and the CEO is Juliana Elstad.

Part of Advanced Medical Technology Association, AdvaMed Accel operates as a medical technology association. The company is based in Washington. The CEO of the American company is Mark A. Augusti.

Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA.

Functional Neuromodulation Ltd. operates as a holding company which engages in the design and development of deep brain stimulation therapies for memory and cognitive disorders. It uses a surgically implanted medical device, similar to a pacemaker, to deliver mild electrical pulses to targeted areas of the brain. The company was founded by Andres Lozano in 2010 and is headquartered in Boston, MA.